SecBot SecBot
6-K ·Filed Sep 9, 2026

CRDL

Cardiol Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001279569-26-000867
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine conference appearance with no material new information.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
CRDL ▼ -42.23% at T+20d
NEUTRAL call -42.23% · α vs SPY -44.18% · entry $2.29 → $1.32
Next anchor: T+60d in 5w
Latest observation: T+32 -65.61% FF3 residual α
Entry = T+0 close
Sep 9, 2026
via day close
T+1d
-13.35%
call -13.35% · α -12.75%
$1.98
settled 7w ago
T+5d
-16.85%
call -16.85% · α -16.19%
$1.90
settled 6w ago
T+20d
-42.23%
call -42.23% · α -44.18%
$1.32
settled 20d ago
T+60d
Pending
in 5w

Price Chart

Loading chart...

Executive Summary

Cardiol Therapeutics announced participation in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The event is routine and does not disclose any material financial, clinical, or strategic updates.

Key Facts

  • Cardiol Therapeutics will participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026, at 10:30 a.m. EDT.
  • The conference is at the Lotte New York Palace Hotel in New York, NY.
  • A live webcast will be available on the Cardiol website under Events & Presentations.
  • The filing includes no financial results, clinical data, or changes to business outlook.

Financial Impact

None – no financial information provided in this filing.

Risk Factors

  • No clinical data or business updates are disclosed, making the filing a non-event for the stock.
  • Over-reaction to routine conference participation could create short-lived volatility.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001279569-26-000867
Document: cardiol6k.htm0001279569-26-000867
Document: 0001279569-26-000867-index-headers.html0001279569-26-000867
Document: 0001279569-26-000867-index.html0001279569-26-000867
Document: 0001279569-26-000867.txt0001279569-26-000867
16 reports for CRDL
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 3 of 6 best @ T+20▲ +30.43%Jul 14, 2026
Filters
Rows
Reports for CRDL — sortable, filterable
TypeNow
Sep 23, 2026
4w ago
SC 13G/A
BULLISH ★ 5/10
$1.77awaiting T+60—$1.13 (−35.88%)
Sep 23, 2026
4w ago
6-K
BULLISH ★ 6/10
$1.77awaiting T+60—$1.13 (−35.88%)
Sep 16, 2026
5w ago
6-K
BULLISH ★ 5/10
$1.90awaiting T+60—$1.13 (−40.26%)
Sep 10, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$2.00awaiting T+60—$1.13 (−43.11%)
Sep 10, 2026
6w ago
6-K
NEUTRAL ★ 4/10
$2.00awaiting T+60—$1.13 (−43.11%)
Sep 9, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$2.29awaiting T+60—$1.13 (−50.33%)
Aug 5, 2026
11w ago
6-K
NEUTRAL ★ 2/10
$1.34awaiting T+60—$1.13 (−15.30%)
Jul 14, 2026
15w ago
6-K
BULLISH ★ 5/10
$1.15 $1.32▲ +14.78%▲ +11.41%$1.13 (−1.30%)
Jul 9, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$0.9920 $1.41▲ +42.14%▲ +40.50%$1.13 (+14.42%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$1.30 $1.96▲ +50.77%▲ +48.04%$1.13 (−12.69%)
Showing 10 of 16

US Market Status

Market Open — Closes in 6h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 9, 2026